So the question arises what chemotherapy or immunotherapy or their combination would be most effective if the patient shows positivity for APC genes while negative for KRAS, NRAS, and BRAF on DNA sequencing, i.e., a patient showing a partial chromosomal instability as per the adenoma-carcinoma sequence model. The gene discussed is KRAS; the disease is carcinoma.